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Abstract Accurate evaluation of programmed cell death,
or apoptosis, in chondrocytes is essential to studying car-
tilage injury. We evaluated four methods of detecting
chondrocyte-programmed cell death in formalin-ﬁxed,
parafﬁn-embedded cartilage after experimental osteo-
chondral fracture. Human osteochondral explants were
subjected to experimental fracture in a manner known to
induce high levels of chondrocyte-programmed cell death.
After 4 days in culture, specimens were ﬁxed and analyzed
for programmed cell death using: (1) terminal deoxynu-
cleotidyl transferase end labeling; (2) DNA denaturation
analysis using an antibody speciﬁc for single-stranded
DNA; (3) immunohistochemistry using antisera speciﬁc for
active caspase-3; and (4) in situ oligonucleotide ligation.
Quantitative analysis of programmed cell death levels for
each technique was performed comparing injured and
uninjured areas of cartilage. We observed differences
between injured and uninjured areas of cartilage using the
four methods. Human cartilage ﬁxed in zinc-formalin and
embedded in parafﬁn is amenable to programmed cell
death analysis using any of four independent methods, each
of which ostensibly has some advantages in terms of
assaying different steps along the apoptotic pathway. Using
the protocols described in this article, investigators may
have additional tools to identify and quantify chondrocytes
undergoing programmed cell death after experimental
cartilage injury.
Introduction
Chondrocyte-programmed cell death (PCD) is a critical
event during normal embryologic development and bone
growth. PCD has been implicated in the pathogenesis of
osteoarthritis, rheumatoid arthritis, and posttraumatic
arthritis, all increasingly common diagnoses in our active
and aging population [3, 11]. A thorough investigation of
chondrocyte PCD is critical to our understanding of
degenerative joint diseases and for developing new thera-
peutic approaches. One of the greatest technical challenges
facing investigators in this ﬁeld of study is the requirement
for accurate, consistent, and convenient methods for iden-
tifying apoptotic chondrocytes in cartilage. The need for
multiple complementary techniques is well accepted as a
result of recognized shortcomings of relying on any single
method for PCD analysis. Chondrocyte PCD analysis is
particularly difﬁcult in parafﬁn-embedded specimens in
which loss of antigenicity can render antibody-based
techniques useless.
Classically, cells undergoing apoptosis were identiﬁed
based on morphologic criteria with characteristic features
further delineated by electron microscopy [10]. Studies
have described the use of standard bright ﬁeld light
microscopy and hematoxylin and eosin staining to identify
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cartilage [1, 11]. However, efforts using this methodology
to assess chondrocyte PCD after experimental cartilage
injury have been inconsistent [16, 17]. One contributing
factor may be that chondrocytes undergoing PCD may not
exhibit classic apoptotic morphologic features for most
other sorts of cells [18].
There are, however, four readily available methods to
detect PCD in ﬁxed, parafﬁn-embedded cartilage samples,
including terminal deoxynucleotidyl transferase end label-
ing (TUNEL), DNA denaturation analysis using anti-single-
stranded DNA (ssDNA) antibody, anti-active caspase-3,
and in situ oligonucleotide ligation (ISOL). TUNEL iden-
tiﬁes apoptotic cells based on DNA fragmentation, which is
one hallmark of apoptosis. The DNA fragmentation results
in large numbers of free 30-OH termini. In the TUNEL
technique, these free ends are enzymatically labeled.
Although TUNEL is by far the most commonly used
method for analyzing chondrocyte PCD in cartilage, sub-
stantial controversy exists concerning its ability to
distinguish between apoptotic and necrotic cell death [8].
When used to study apoptosis in osteoarthritic cartilage,
TUNEL is believed to overestimate apoptosis [1]. In
hepatocytes, TUNEL is nonspeciﬁc for PCD because other
methods of cell death involve DNA fragmentation [8].
DNA denaturation analysis using anti-ssDNA antibody
is based on the selective denaturing of DNA in apoptotic
cells with heat treatment. The increased sensitivity of DNA
to heat treatment observed in apoptotic cells is believed to
be the result of disruption of DNA-histone interactions and
is independent of DNA strand breaks [4]. This technique
may identify cells at earlier stages of apoptosis than
TUNEL [23]. Most importantly, this technique is highly
speciﬁc for cells undergoing PCD and does not label cells
undergoing necrotic cell death [7].
Caspase-3 is a critical enzymatic mediator of PCD and
appears to play key roles in the late initiation and early
execution phases of apoptosis. Detection of activated cas-
pase-3 using antibodies speciﬁc for the active enzyme has
been used successfully in a wide variety of tissues [13, 15,
22]. Investigators studying chondrocyte PCD in osteoar-
thritic cartilage have reported good correlation between
anti-active caspase-3 staining and TUNEL analysis [14].
ISOL, like TUNEL, detects DNA fragmentation that
occurs in apoptotic cells. However, ISOL is more speciﬁc
than TUNEL because it labels only double-stranded DNA
fragments with blunt ends or single 30 base overhangs [5,
9]. These types of free ends are much more common in
cells undergoing PCD than in cells undergoing necrosis [5].
Of these four techniques, only TUNEL has been widely
used for analysis of PCD in cartilage [3].
To compare these methods, we used two cartilage
sources with known apoptotic cells. First, we mechanically
induced PCD with a simulated intraarticular fracture.
Second, we used human growth plate cartilage in which
PCD occurs during the process of endochondral
ossiﬁcation.
Materials and Methods
We obtained human tibial plateau osteochondral specimens
from a skeletally mature male at the end of his second
decade of life undergoing limb salvage for a distal femoral
tumor not involving the regions of the specimens. After
surgical excision, the specimen was stored in sterile lac-
tated Ringer’s solution at room temperature until the
experimental cartilage injury was created (approximately
4 hours after excision). To create the injury, we used a
curette to make a single sagittal groove beneath the central
portion of the lateral plateau penetrating through the can-
cellous bone into the subchondral bone. The specimen then
was subjected to a three-point bending force across the
weakened area until the cartilage and subchondral bone
fractured. The osteochondral specimens then were placed
in standard cell culture conditions with DMEM for 4 days
at 37C in the incubator with 5% CO2. The specimens then
were ﬁxed in zinc-buffered formalin (Z-Fix; Anatech Ltd,
Battle Creek, MI) at 4C overnight. Specimens were
dehydrated, embedded in parafﬁn, sectioned at 7-lm
thickness, and mounted on Superfrost
1 Plus slides (Fisher
Scientiﬁc, Pittsburgh, PA). Sections were deparafﬁnized in
xylene and rehydrated before subsequent analysis. A min-
imum of four near-adjacent sections were analyzed by each
of the methods described subsequently.
Optimization of the signal-to-noise ratio involved
adjusting the duration and dose of proteinase K digestion
for all techniques, whereas TUNEL staining required
dilution of TdT concentrations. Excessive proteinase K
digestion created excess background noise. The absence of
positive staining in areas of the growth plate where no
apoptosis is believed to occur shows these techniques have
sufﬁcient speciﬁcity. The growth plate cartilage was
obtained from one surgical specimen taken at the time of
epiphyseodesis, washed in saline, and immediately ﬁxed in
Z-ﬁx. After decalciﬁcation of these specimens, using
0.45 mol/L EDTA and 0.1 mol/L Tris buffer, the growth
plates were dehydrated, embedded in parafﬁn, and sec-
tioned at 7-lm thickness. A minimum of four sections then
was analyzed using each of the same protocols.
Detection of double-stranded DNA breaks by TUNEL
was performed using direct incorporation of ﬂuorescein-
labeled nucleotides with modiﬁcation of the protocol pro-
vided with the ApopTag
1 Fluorescein Direct (Millipore
Corp, Bedford, MA). After deparafﬁnization and rehydra-
tion, the samples were treated with 20 lg/mL proteinase K
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the samples were incubated in Equilibrium Buffer for
30 seconds. Fifty-ﬁve microliters of TUNEL reaction
mixture consisting of 12.4 lL terminal deoxynucleotidyl
transferase enzyme, 28.9 lL reaction buffer, and 68.8 lL
sterile phosphate-buffered saline (PBS) was added to the
sections and incubated at 37C in a humidiﬁed chamber for
1 hour. We found this dilution of the TdT reaction mixture
was useful in reducing background noise from prior
experiments. The reaction was stopped with stop/wash
buffer and incubated for 10 minutes. Slides then were
washed in PBS, counterstained with DAPI, 40,6-diamidino-
2-phenylindole (Vector Labs, Burlingame, CA), and
observed under ﬂuorescent microscopy.
Apoptosis detection using DNA denaturation analysis
was performed following a protocol provided by Chemicon
(Temecula, CA). After deparafﬁnization and rehydration,
sections were permeabilized in 0.1 mg/mL saponin for
20 minutes and washed in PBS. Sections then were
digested with 10 lg/mL proteinase K for 10 minutes and
washed in distilled H2O. Slides were incubated in 50%
formamide w/v in distilled H2O for 20 minutes at 56 to
60C and then washed in ice-cold PBS for 5 minutes.
Endogenous peroxide was quenched. Nonspeciﬁc binding
was blocked with 3% nonfat dry milk. The primary anti-
body, anti-mouse F7-26 anti-ssDNA (Millipore) at 1:10
dilution, was applied for 30 minutes at room temperature in
a humidiﬁed chamber and then washed in PBS. The sec-
ondary antibody, biotinylated anti-mouse IgM (Vector
Labs) at 1:200 dilution, was applied for 30 minutes and
washed in PBS. Streptavidin-peroxidase (Millipore) incu-
bation for 30 minutes was followed by development in
3,30-diaminobenzidine (DAB) (Millipore), washed in PBS
and distilled H2O, and counterstained with DAPI (Vector
Labs). Negative controls were run without primary
antibody.
For the anti-activated caspase-3 method, sections were
deparafﬁnized, rehydrated, and then incubated in 1 mg/mL
hyaluronidase (Sigma-Aldrich Corp, St Louis, MO) in PBS
for 60 minutes at 37C and washed in PBS. Endogenous
peroxide then was quenched. Nonspeciﬁc binding was
blocked with 5% normal goat serum. Proteinase K at
10 lg/mL was applied for 10 minutes and sections were
washed in PBS. Sections then were incubated in the pri-
mary antibody, 1:100 anti-active caspase-3 pAb rabbit IgG
(Promega Corp, Madison, WI) overnight at 4C, followed
by anti-rabbit IgG biotinylated antibody (Vector Labs) at
1:100 dilution in PBS, and then streptavidin-peroxidase.
Slides were developed in DAB, washed in PBS and dis-
tilled H2O, and counterstained with DAPI. Negative
controls were run without primary antibody incubation.
Single-base 30 overhangs and blunt ends in double-
stranded DNA were detected using ISOL following the
protocol provided in the ApopTag
1 ISOL kit (Millipore).
After deparafﬁnization and rehydration, endogenous per-
oxide was quenched with 3% hydrogen, and the sections
then were incubated in 10 lg/mL proteinase K for
10 minutes. Sixty microliters working-strength DNA ligase
solution, 54 lL biotin-labeled oligonucleotide, and 6 lL
T4 DNA ligase were placed on the sections, and the sec-
tions were incubated in a humidiﬁed chamber for 14 hours
at 20C. Oligonucleotides speciﬁc for single-base 30 ends
(Oligo A) and blunt ends (Oligo B) were used with single-
base 30 detection being more speciﬁc for apoptosis and
blunt end detection being more sensitive. After incubation
in T4 DNA ligase, the sections were washed in PBS, and
streptavidin-peroxidase was applied for 30 minutes. The
signal was developed in DAB, the reaction was stopped
with PBS followed by distilled H2O washes, and the slides
were counterstained in DAPI.
For histologic analysis, near-adjacent sections were
stained with hematoxylin and eosin (Fisher Scientiﬁc,
Fairlawn, NJ) and safranin O (Fisher Scientiﬁc) using
standard methods to assess proteoglycan loss.
For the injured cartilage specimens, the injury zone was
deﬁned as the area of cartilage starting from the edge of the
fractured cartilage and extending up to 1.3 mm away from
the injury site. The control zone was deﬁned as an area of
cartilage approximately 10 mm from the cartilage fracture
site. We intentionally chose areas that should be positive
and negative. The deep layer provides a better control for
true-negatives in testing detection methods as a result of
processing and culture conditions that can affect the
superﬁcial layer of cartilage. This study was not designed
to look at the model system of the injury, but rather the
ability of these detection methods to distinguish between
positive and negative cells. With superﬁcial cartilage, there
may be a baseline level of apoptosis resulting from storage.
The deep cartilage should not be expected to have cells
undergoing PCD.
Each zone of analysis measured 1.3 mm 9 1.3 mm
with the depth of visualization determined by the depth of
ﬁeld of the microscope objective. Images were captured
digitally at one-megapixel resolution with a Zeiss Axio-
Cam mounted on an Axioskop 2 microscope (Carl Zeiss,
Inc, Thornwood, NY). Appropriate ﬁlters were used for
ﬂuorescence-based techniques. We (AD) performed semi-
automated cell counting using Photoshop
1 (Adobe
Systems Inc, San Jose, CA) and Scion Image (Scion Corp,
Frederick, MD) software packages optimized to detect cells
based on nuclear and/or cytoplasmic staining. The apop-
totic index for each area was calculated by dividing the
number of positive cells by the total number of cells in the
area of analysis.
Results are presented as the apoptotic index in per-
centage ± standard error of the mean. We compared the
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123apoptotic indices from the injury zone with those of the
internal control of the zone of chondrocytes in the central
area and also between detection methods in the injury zone,
using unpaired two-tailed t tests. We performed all analy-
ses using GraphPad Prism
1 (GraphPad Software, Inc, La
Jolla, CA).
Results
All four methods when used for chondrocyte PCD showed
differences when comparing the injury zone with the
control (Table 1). In addition, similar spatial patterns of
staining were observed using all techniques (Fig. 1). The
magnitude of positive signal also was similar in all samples
(Fig. 2).
Many TUNEL-positive cells were observed in the zone
of injury with an apoptotic index of 46.9% ± 5.2%. The
ﬂuorescence was restricted primarily to the nucleus in
positive cells; only a handful of positive cells had signal in
the cytoplasm. Very few positive TUNEL cells were seen
in the control zone with an apoptotic index of
4.9% ± 0.9%, which was smaller (p\0.0001) than the
apoptotic index observed in the injury zone (Fig. 1B).
Immunohistochemistry using an anti-ssDNA antibody
after heat treatment of sections in formamide identiﬁed
positive cells in a similar distribution. In these positive
cells, the DAB signal was restricted to nuclear staining. No
cytoplasmic staining and very little background staining
were observed. A larger (p = 0.0007) apoptotic index was
observed for the zone of injury (40.4% ± 5.9%) than that
observed for the control zone (4.9% ± 0.9%) (Fig. 1C).
Immunohistochemistry using anti-active caspase-3
antisera identiﬁed positive cells with the DAB signal in the
cytoplasm of affected cells. In the zone of injury, chon-
drocytes with active caspase-3 were clearly identiﬁed, with
a higher (p = 0.0002) apoptotic index in the injured
compared with the control zone (54.1% ± 6.5% versus
6.5% ± 2.2%, respectively) (Fig. 1D).
ISOL-labeled cells had staining primarily in the nucleus
of chondrocytes. Background matrix staining by DAB was
slightly higher using this technique compared with the
other techniques. Similar results were obtained using either
the oligonucleotide speciﬁc for single-base overhangs
(Oligo A) or the oligonucleotide speciﬁc for blunt ends
(Oligo B). With Oligo A, the zone of injury had a larger
(p = 0.0001) apoptotic index (45.3% ± 5.9%) than the
control zone (4.0% ± 1.5%) (Fig. 1E). With Oligo B, the
zone of injury also had a larger (p\0.0001) apoptotic
index (39.5% ± 5.2%) than the zone away from injury
(7.0% ± 1.7%).
Safranin O staining showed diminished staining in the
area adjacent to the injury edge, suggesting disruption of
cartilage matrix. This correlated with areas where PCD was
detected by the previously described methods. In the con-
trol zone, there was strong safranin red staining.
Hematoxylin and eosin staining revealed slightly reduced
cell numbers just adjacent to the injury edge. A few cells
with irregular, pyknotic nuclei occasionally were observed
in the injured area, whereas none were seen in the control
zone.
Qualitative examination of the growth plate cartilage
using the previously described protocols revealed apoptotic
cells only localized to the hypertrophic zone. The hyper-
trophic zone was identiﬁed by visually scanning through
the entire slide section. Overall incidence of positive
staining cells was very low and variable across the section,
even in the hypertrophic zones. Scanning of the entire
slides revealed all positive cells were in the hypertrophic
zone. No positively staining chondrocytes were seen in any
other area (Fig. 3). These data are presented qualitatively
given the heterogeneity in the growth plate hypertrophic
zone.
When comparing the different PCD detection methods
with each other in a pair-wise manner, there were no sta-
tistical differences in which p\0.05.
Discussion
Traditionally, cells undergoing apoptosis were identiﬁed
based on morphologic criteria by light microscopy with
characteristic features further delineated by electron
microscopy [10]. This method is limited as a result of the
inability to assay a large area of cartilage, making it highly
dependent on sample selection. In addition, chondrocytes
undergoing PCD may not exhibit the apoptotic appearances
of other cells [18]. Therefore, we compared four methods
of PCD detection, which target different characteristics of
PCD—DNA fragmentation (TUNEL and ISOL), DNA
Table 1. Summary of ﬁndings
Apoptotic marker Apoptotic index* p Value
Zone of
injury
Zone away
from injury
TUNEL 46.9 ± 5.2 4.9 ± 0.9 \0.05
ssDNA 40.4 ± 5.9 2.8 ± 0.7 \0.05
Anti-caspase-3 54.1 ± 6.5 6.5 ± 2.2 \0.05
ISOL A 45.3 ± 5.9 4.0 ± 1.5 \0.05
ISOL B 39.5 ± 5.2 7.0 ± 1.7 \0.05
* Values expressed as percentage ± standard error of the mean;
TUNEL = terminal deoxynucleotidyl transferase end labeling;
ssDNA = DNA denaturation analysis using anti single-stranded
DNA antibody; ISOL = in situ oligonucleotide ligation.
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intermediates (anti-caspase3)—and studied each method in
injured and growth plate cartilage.
One limitation of our study is the use of a single source
specimen for our intraarticular fracture model. Other car-
tilage specimens could show a different response to the
same injury given the age of the donor patient and initial
quality of the cartilage. However, one advantage of using a
single specimen is that it reduces the variability between
different samples. In addition, the slides chosen for anal-
ysis for the different assays were taken from alternating
slides of adjacent sections, so each technique was
Fig. 1A–E Photomicrographs (Stain,
Safranin O (A) and DAB primary
antibody staining with Fast Green
counter stain (B–E); original magniﬁ-
cation, 910) compare (A) the injured
zone and the control zone in (B)
TUNEL, (C) ssDNA, (D) anti-active
caspase-3, and (E) ISOL. The break in
the cartilage is to the right of the injured
zone images. TUNEL = terminal
deoxynucleotidyl transferase end label-
ing; ssDNA = DNA denaturation
analysis using anti single-stranded
DNA antibody; ISOL = in situ oligo-
nucleotide ligation.
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Fig. 2 A graph compares the apoptotic indices in the injured zone
and control zone using TUNEL, ssDNA, anti-active caspase-3, ISOL
A (single 30 base overhang), and ISOL B (blunt DNA ends). Error
bars represent standard errors of the mean. The apoptotic indices in
the control versus the injured zones were statistically different in all
test groups; the representative p values are above each paired control
and injured group. TUNEL = terminal deoxynucleotidyl transferase
end labeling; ssDNA = DNA denaturation analysis using anti single-
stranded DNA antibody; ISOL = in situ oligonucleotide ligation.
Fig. 3A–D Photomicrographs
(Stain, A ﬂuorescein with DAPI
counterstain, B–D DAB for pri-
mary antibody with DAPI
counterstain; original magniﬁca-
tion, 920) show growth plate
cartilage stained with (A) TUN-
EL, (B) ssDNA, (C) anti-active
caspase-3, and (D) ISOL A. In all
techniques, positive cells were
observed only in the hypertro-
phic zone of the growth plate
cartilage, showing good spatial
distribution for these techniques.
TUNEL = terminal deoxynucleo-
tidyl transferase end labeling;
ISOL = in situ oligonucleotide
ligation; ssDNA = DNA dena-
turation analysis using anti-
single-stranded DNA antibody.
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cally distant area as a control is analogous to using a
segment of cartilage that had not been subjected to the
three-point break. It is well known that different areas of
articular cartilage have different thickness, material prop-
erties, and likely cellular environments, and by using a
geographic control on the same section, we hoped to
minimize this variability.
We did not intend to show a rate of PCD after this type
of injury model, but rather to look at the consistency of
different methods of PCD detection. Other methods of
cartilage injury may produce different results attributable
to a difference in proportion of apoptosis to necrosis and/or
the timing of apoptotic events. We did not perform a time
course of analysis to see if each method would have dif-
ferent peaks of PCD, which would be plausible given that
they detect different stages of PCD. Our study was not
speciﬁcally designed to prove each method is equivalent or
interchangeable in ﬁnding rates of apoptosis, but rather that
all these methods can be used to detect apoptotic versus
nonapoptotic control chondrocytes.
As research in this ﬁeld has progressed, speciﬁc markers
based on biologic processes unique to PCD have been
identiﬁed and exploited in assays designed to identify
apoptotic cells. However, many of these assays can be
performed only on living cells and often are optimized for
cells grown in tissue culture [20]. Because chondrocyte
biology is intimately tied to the surrounding cartilage
matrix, the ability to study chondrocyte PCD in cartilage
after ﬁxation and sectioning is often desirable and/or
necessary.
To allow for multiple types of analyses of near-adjacent
sections from one specimen, a method of cartilage ﬁxation
amenable to all of the proposed techniques was necessary.
Unfortunately, relatively few PCD markers are preserved
after traditional formalin ﬁxation and parafﬁn embedding.
Consequently, one critical factor was the use of a zinc-
formalin ﬁxative such as Z-Fix instead of standard buffered
formalin. Zinc ions are believed to preserve immunoreac-
tivity by maintaining the tertiary structure of proteins [4].
We noted markedly improved sensitivity and speciﬁcity
using zinc-formalin ﬁxation compared with 10% neutral-
buffered formalin ﬁxation with several antibodies, includ-
ing anti-active caspase-3. Detection of active caspase-3
after ﬁxation in neutral-buffered formalin required antigen
retrieval in citrate and postlabeling signal enhancement
using Tyramide Signal Ampliﬁcation
TM (Perkin-Elmer,
Boston, MA) (data not shown). These additional steps not
only resulted in higher nonspeciﬁc background staining,
but also tended to cause smaller cartilage sections to detach
from the slides.
One potential limitation of using active caspase-3 as a
marker for apoptosis is evidence that PCD, under certain
conditions, can be caspase-independent [21]. However, all
existing data indicate chondrocyte PCD requires caspase-3
activation [12, 14, 15]. Regardless, active caspase-3 is only
one of several potential PCD markers amenable to detec-
tion using immunohistochemistry.
Alternative PCD markers for which commercially
available antibodies are available include the 85-kD PARP
cleavage product (anti-PARP p85; Promega) and a neo-
epitope produced by cleavage of cytokeratin 18 (M30
cytodeath; Roche). Neither was tested in the current study;
however, we have successfully used the PARP p85 anti-
body in other experiments using zinc formalin ﬁxatives
(data not shown). To our knowledge, the M30 cytodeath
reagent has not been used successfully for detecting
apoptosis in cartilage.
The use of zinc-buffered formalin did not appear to have
any detrimental effects on TUNEL, DNA denaturing
analysis, or ISOL despite anecdotal reports that zinc could
interfere with some types of DNA analyses such as in situ
hybridization [2, 19]. However, each technique required
optimization to yield the best results. TUNEL, in particu-
lar, was quite sensitive to duration of ﬁxation, matrix
digestion conditions, terminal deoxynucleotidyl transferase
enzyme concentration, and substrate concentration. When
performed following the protocol described in this article,
TUNEL yielded results directly comparable to DNA
denaturing analysis and ISOL, two techniques reportedly
much more speciﬁc for apoptotic cells [5, 6]. One factor
that may contribute to the observed consistency is a rela-
tively low rate of necrotic cell death in the model of
cartilage injury used in this study. Therefore, situations in
which necrosis plays a greater role may lead to a relatively
higher percentage of TUNEL-positive cells compared with
DNA denaturing analysis and ISOL.
The images from the growth plate cartilage analysis
suggest these methods are able to detect chondrocytes
undergoing PCD in the hypertrophic zone. Our low back-
ground level of staining also suggests the ﬁxation and
specimen preparation steps did not induce artifacts that
would lead to false-positive staining.
We found no differences in the apoptotic indices with
these four techniques. However, our primary objective was
not to compare these techniques with each other, but rather
to determine whether they are complementary in the
detection of apoptosis. Increasing our sample size may
have given us sufﬁcient power to detect differences among
these methods. However, the differences would likely not
be large enough to change our basic conclusions.
These results should be used in the evaluation of
detection of apoptosis in parafﬁn embedded sections. A
limitation is that we did not look for total cell viability with
live/dead staining. Preparing these samples for live/dead
staining, for vibratome sectioning, would involve removing
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123the cartilage layer from the calciﬁed cartilage or sub-
chondral bone, adding an additional injury to the cartilage,
which would not be present on the ﬁxed samples.
Based on our data, we conclude TUNEL, ssDNA, anti-
active caspase-3, and ISOL are each able to distinguish
between apoptotic and nonapototic chondrocytes under the
described experimental conditions. All four techniques
appeared well suited for detecting chondrocyte PCD in
parafﬁn-embedded cartilage after zinc formalin ﬁxation,
precluding the need for multiple ﬁxation methods. The
observation that independent markers for PCD identiﬁed
the same populations of chondrocytes increases our conﬁ-
dence that these cells are undergoing PCD and not necrosis.
However, limitations with each technique make reliance on
any single detection method unwise, and we advocate using
at least two of these complementary techniques in any
analysis of cartilage PCD. With the described techniques
added to their arsenals, researchers should be able to
investigate the mechanisms and pathways of chondrocyte
PCD with increased conﬁdence in the validity of their
ﬁndings.
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